Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nectar Lifesciences Ltd. ( (IN:NECLIFE) ) has shared an announcement.
Nectar Lifesciences Ltd. announced the appointment of Mr. Sushil Kapoor as an additional Director and Wholetime Director designated as Director (Finance), effective December 4, 2025. Additionally, the company has approved a buyback of equity shares amounting to INR 81 crore at a price of INR 27 per share, representing up to 13.38% of the total equity shares. This buyback is part of a strategic move to enhance shareholder value, with the promoters opting not to participate, and is managed by Master Capital Services Limited.
More about Nectar Lifesciences Ltd.
Nectar Lifesciences Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its emphasis on quality and innovation, serving both domestic and international markets.
Average Trading Volume: 90,726
Technical Sentiment Signal: Sell
Current Market Cap: 3.91B INR
For detailed information about NECLIFE stock, go to TipRanks’ Stock Analysis page.